Creating a New Kind of Doctor
We recruit and train physician leaders as comfortable taking on systemic challenges in health as caring for individual patients.
ARE YOU ONE?
Radical Collaboration. Real-World Impact.
Texas expertise fuels the discovery, delivery and diffusion of the next generation of preventions, diagnoses, treatments and cures.
LET'S GO
World Class. Close to Home.
We’re working to make person-centered, integrated care the standard in Central Texas and beyond.
Health Starts Here
More Information
GET CARE
Meet Dell Med
We’re rethinking the role of academic medicine in improving health — and doing so with a unique focus on our community.
ABOUT US
More Information
EXPLORE
Make an Appointment Give Faculty Students Alumni Directory

Neurology Department Lecture: Delirium

Location: Hybrid: Health Learning Building (HLB 5.201) and Zoom

Address: 1501 Red River St., Austin, Texas 78712 | View Map »

Date: Tuesday, February 10, 2026

Time: 7:30–8:30 a.m.

Contact: Sharon Green

Category:

About the Event

In this installment of Neurology Department Lecture series, Shouri Lahiri, M.D., presents “Delirium: Clinical Implications, Pathophysiology and Scientific Advances.” Lahiri is an associate professor in neurology, neurosurgery and biomedical sciences at Cedars-Sinai Medical Center. He also serves as the director for Neurocritical Care Research and the Neurosciences Critical Care Unit.

In-person attendees should arrive by 7:15 a.m. Breakfast will be available.

Email Sharon Green for the Zoom information.

Learning Objectives

By the end of this presentation, the audience participant should be able to:

  1. Describe the clinical significance of delirium and its relationship with long-term cognitive decline and dementia.
  2. Explain how acute systemic illnesses such as urinary tract infection and ventilator-induced lung injury may trigger delirium through IL-6–mediated neuroimmune pathways.
  3. Identify emerging mechanism-based therapeutic strategies — including early antimicrobials, estrogenic neuroprotection and IL-6 trans-signaling inhibition — that may prevent or ameliorate delirium.